The COVID-19 epidemic introduced significant systems- and disease-based uncertainty into Abdominal Aortic Aneurysm (AAA) rupture management. The goal of this work was to evaluate whether short-term AAA rupture outcomes during COVID-19 were comparable to pre-COVID era outcomes and to explore the impact of COVID status and COVID era healthcare systems restrictions on AAA rupture outcomes. The Vascular Quality Initiative (VQI) database was queried for all ruptured AAAs that underwent intervention from January 1st, 2019 to August 31st, 2022. Patients were divided into pre-COVID (1/1/19-12/31/19) and COVID (4/1/20-8/31/22) cohorts. The COVID group was subdivided into COVID unknown, COVID-, and COVID+ subgroups. 1/1-3/31/2020 was excluded due to COVID status uncertainty during this time. For the univariate analysis, categorical variables were compared using the Χ2 test; continuous variables were compared either using a two-tailed heteroscedastic Student's T-test or ANOVA. The multivariate analysis was performed using logistic regression module of IBM SPSS Statistics V25. 2,145 cases (pre-COVID: 745; COVID: 1,400) of AAA rupture were collected. Only 4 documented cases of rupture repair occurred during April 2020 compared to pre-COVID average of 62.1 cases/month (Figure 1). Rupture case numbers recovered to pre-COVID volumes by September 2020. COVID+ patients were less likely to be transferred from outside institutions and experienced delays to OR arrival (time of symptom start to incision of 43.3 hours for COVID+ vs 24.4 hours for all COVID era). Although the COVID+ mortality rate for AAA rupture was higher the overall COVID era mortality rate (31.4% vs. 24.9%) in the univariate analysis, this mortality difference went away with comorbid adjustments. However, COVID+ patients were more likely to have untreated COPD, require post-op ventilatory & vasopressor support, and undergo amputation rather than salvage for acute leg ischemia (Table 1). No statistically significant differences between pre-COVID and COVID cohorts were observed with gender, race, age, smoking, cardiac history or perioperative events, dialysis or pre-op creatinine, prior aneurysm repair, intervention choice of open vs EVAR, maximum AAA diameter, or post-operative length of stay. The COVID-19 epidemic introduced numerous structural changes in healthcare, creating delays and obstacles to patients' abilities to receive pre-hospital and hospital care. Despite these systems-level obstacles with a highly morbid disease process, COVID era patients were not at an increased risk for mortality regardless of COVID status and were largely comparable to pre-COVID era patients.
Read full abstract